Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy.

Nat Commun · 2022 · PMC9126915 · PMID 35606362

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The combination of VEGF and vimentin further suppressed VE-cadherin expression, although this did not reach statistical significance (Fig. 2d ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.